Test Price
140 AED✅ Home Collection Available
Cytomegalovirus (CMV) IgG Advantage Test – Immunity Assessment in UAE
Executive Summary & Core Metrics
The CMV IgG Advantage test determines past cytomegalovirus exposure and immunity status using dual-methodology (CLIA + confirmatory ELISA) with same-day reporting. This serological assessment is essential for preconception planning, pregnancy risk stratification, and immune status evaluation across the UAE.
- Diagnostic Accuracy: >99.9% sensitivity and specificity via ISO-accredited dual-methodology processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Post-Test Guidance: Telephonic clinical consultation with a DHA-licensed general practitioner to review results.
- Insurance & Billing: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Cytomegalovirus (CMV) IgG Advantage test employs a dual-assay strategy combining Chemiluminescent Immunoassay (CLIA) for high-throughput screening with confirmatory Enzyme-Linked Immunosorbent Assay (ELISA) for definitive IgG detection. This two-tier approach delivers superior diagnostic confidence for immunity assessment in preconception, prenatal, and general health contexts. The test requires a standard peripheral venous blood sample and provides same-day results when collected before 9 AM on scheduled processing days.
| Feature | CMV IgG Advantage Test | Standard CMV IgG (ELISA Only) |
|---|---|---|
| Diagnostic Precision | >99.9% sensitivity & specificity; CLIA + confirmatory ELISA | Standard ELISA, variable sensitivity (~90–95%) |
| Methodology | Chemiluminescent Immunoassay (CLIA) + Enzyme Immunoassay (ELISA) | ELISA only |
| Result Turnaround | Same-day report (Mon/Wed/Fri by 9 AM collection) | 1–3 business days |
| Sample Collection | VIP Mobile Phlebotomy with temperature-controlled cold-chain logistics | Clinic-based venipuncture only |
Physician Insight & Safety Protocols
“A positive CMV IgG Advantage result indicates past exposure and established immunity, which is critical for risk assessment during pregnancy and for immunocompromised individuals. However, serological results must always be interpreted alongside clinical history and, where indicated, correlated with IgM and avidity testing. I recommend discussing all findings with your primary care physician for personalized management.”
— Dr. Ajay Singh | General Practitioner | DHA Registration ID: 36234132
Clinical Advisory & Patient Safety
Important Pre-Test Guidance
This test is designed to determine immunity status and past exposure to cytomegalovirus. It is not a diagnostic tool for acute primary CMV infection. Patients experiencing symptoms suggestive of active infection—such as persistent fever, unexplained jaundice, visual disturbances, or severe fatigue—should seek immediate medical evaluation rather than relying solely on serological screening. Inform your phlebotomist of any recent febrile illness, immunosuppressive therapy, or blood transfusion history, as these factors may transiently affect IgG levels.
Exclusion Criteria & Red Flags
- This test is not intended for diagnosis of acute primary CMV infection; if symptoms including fever, jaundice, visual disturbances, or severe fatigue are present, seek urgent medical attention immediately.
- Not recommended for individuals currently receiving high-dose immunosuppressants or chemotherapy that may significantly alter immunoglobulin levels.
- Acute febrile illness within the past 24 hours may temporarily influence serological results; consider rescheduling collection once symptoms have resolved.
Patient FAQ & Clinical Guidance
1. What does a positive CMV IgG test result indicate?
A positive CMV IgG Advantage test confirms past exposure to cytomegalovirus and the presence of protective immunity, validated through dual CLIA and ELISA methodology. In pregnancy, this typically indicates prior infection and a very low risk of congenital transmission. However, results must be interpreted alongside clinical history and, if needed, IgM and IgG avidity testing to differentiate recent from remote infection.
2. Is any special preparation required before the blood draw?
No special preparation is necessary; you may eat, drink, and take your regular medications as prescribed. Please inform the phlebotomist about any current medications, recent illnesses, or known immunocompromised status, as these may affect test interpretation. For pregnant women, no additional precautions are needed beyond standard venipuncture protocols.
3. How quickly will I receive my CMV IgG Advantage result?
Your result will be released the same day if your blood sample is collected and received at our laboratory before 9 AM on Monday, Wednesday, or Friday. This rapid turnaround enables timely clinical decision-making for preconception counseling, prenatal risk assessment, and immune status verification. Reports are delivered electronically via secure patient portal and WhatsApp.
4. Can this test be performed during pregnancy?
Yes, the CMV IgG Advantage test is routinely used in pregnancy to determine maternal immunity status. Knowing your CMV IgG status helps stratify risk for primary infection during pregnancy, which is the leading cause of congenital CMV transmission. The test requires only a standard blood draw and poses no risk to the mother or fetus. Discuss your results with your obstetrician for personalized guidance.
UAE Regulatory & Data Privacy Adherence
All clinical testing, data handling, and patient communication conducted under this service fully comply with the following UAE federal legislations:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of personal health data with explicit patient consent and data minimization principles.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating telemedicine, electronic health records, and digital communication of diagnostic results.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – establishing the framework for clinical safety, diagnostic accuracy, and patient consent prior to any laboratory procedure.
Your sample and personal data are processed in ISO-accredited laboratories under strict confidentiality protocols. You have the right to access, rectify, or request deletion of your data in accordance with PDPL provisions.
Clinical & Logistical Metadata
| Test Name | Cytomegalovirus (CMV) IgG Advantage Test |
| Price (AED) | 140 AED |
| Turnaround Time | Same day (Mon/Wed/Fri by 9 AM collection); 1–3 days for samples received after cutoff |
| Sample Type / Matrix | Peripheral whole blood, serum (SST) |
| Methodology Used | Chemiluminescent Immunoassay (CLIA) + Enzyme-Linked Immunosorbent Assay (ELISA) |
| ICD-10-CM Code | B25.9 |
| LOINC Code | 13950-1 |
| DHA Facility License & Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians